Shenghu Guo

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University

发表论文 17 篇 · 总被引 305 次 · h-index 8

代表论文

• Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin (2019 · Biomedicine & Pharmacotherapy · 被引 88)
• Long non-coding RNA TUG1 enhances chemosensitivity in non-small cell lung cancer by impairing microRNA-221-dependent PTEN inhibition (2019 · Aging · 被引 69)
• Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer (2014 · Experimental and Therapeutic Medicine · 被引 52)
• Bortezomib prevents oncogenesis and bone metastasis of prostate cancer by inhibiting WWP1, Smurf1 and Smurf2 (2014 · International Journal of Oncology · 被引 37)
• FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer (2023 · American Journal Of Pathology · 被引 18)
• Immune biomarkers in circulating cells of NSCLC patients can effectively evaluate the efficacy of chemotherapy combined with anti-PD-1 therapy (2025 · Frontiers in Immunology · 被引 11)